Friends of Cancer Research Annual Meeting

Friends of Cancer Research (Friends) is proud to host our Annual Meeting to address critical issues in the development of new oncology drugs and diagnostics. This meeting brings together leaders in cancer drug development, federal health and regulatory agencies, academic research, the private sector, and patient advocates for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies.

This year’s meeting features panels and experts that will propose unique approaches toward the following vital topics in drug development:

• Characterizing the Use of External Controls for Augmenting Randomized Control Arms and Confirming Benefit
• Immuno-Oncology Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy
• Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products

Click HERE to view the full agenda. For more information or to RSVP, click the link above or contact Heather Chaney at hchaney@focr.org or (202) 944-6719.